JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
CCCC Financials - C4 Therapeutics Income & Cash Flow | Ledgeburg
CCCC - C4 Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary CCCC Stock
Financials
Financials CCCC Stock
Loading...
Loading...
Income Statement
Income Statement CCCC Stock
Balance Sheet
Balance Sheet CCCC Stock
Cash Flow Statement
Cash Flow Statement CCCC Stock
Loading...
Loading...
Home
Stocks
C4 Therapeutics, Inc. (CCCC)
Financials
Financials of CCCC
Loading...
Loading...
Loading...
Loading...
Revenue
$35.947M
Operating Income
$-115.222M
Net Income
$-104.994M
Share Count (Basic)
82.894459M
Operating Cash Flow
$-98.694M
Free Cash Flow
$-99.301M
Cash And Short-Term Equivalents
$74.603M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
50M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
2M
4M
6M
8M
10M
12M
Q1 FY25
Q2 FY25
Annual
Quarterly
Net Income $USD
-130M
-120M
-110M
-100M
-90M
-80M
Annual
Quarterly
Margins
Gross
Operating
Net
-700%
-600%
-500%
-400%
-300%
-200%
FY2025
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-30M
-25M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-450%
-400%
-350%
-300%
-250%
-200%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26